|
|
||||||||
Papers In Press, published online ahead of print December 30, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Physiological Nursing, University of California San Francisco, San Francisco, CA 94143-0160
Corresponding Author: bradley.aouizerat{at}nursing.ucsf.edu
Background: Phospholipid Transfer Protein (PLTP) participates in key processes in lipoprotein metabolism including inter-particle phospholipid transfer, remodeling of HDL, cholesterol and phospholipid efflux from peripheral tissues, and the production of hepatic VLDL. The impact of PLTP on reverse cholesterol transport suggests the gene may harbor sequence anomalies that contribute to disorders of HDL metabolism. Methods and Results: The human PLTP gene was screened for sequence anomalies by DNA melting analysis in 276 subjects with Hypoalphalipoproteinemia (HA) and 364 controls. The association with plasma lipid parameters was evaluated. Results: We discovered 18 sequence variations, including 4 missense mutations and a novel polymorphism (c.-34G>C). In healthy controls, the c.-34G>C minor allele was associated with higher HDL-cholesterol (HDL-C), and was depleted in subjects with HA. Linear regression models predict that possession of the rare allele decreases plasma triglyceride (TG) and TG/HDL-C, and elevates HDL-C independent of TG. Decreased PLTP activity was observed in one (p.R235W) of four (p.E72G, p.S119A, p.S124Y, and p.R235W) mutations in an in vitro activity assay. Conclusions: These findings indicate that PLTP gene variation is an important determinant of plasma lipoproteins and impacts disorders of HDL metabolism.
Revised on December 6, 2005
Accepted on December 30, 2005
Genetic variation of PLTP modulates lipoprotein profiles in hypoalphalipoproteinemia
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. S. Kiss, N. Kavaslar, K.-i. Okuhira, M. W. Freeman, S. Walter, R. W. Milne, R. McPherson, and Y. L. Marcel Genetic Etiology of Isolated Low HDL Syndrome: Incidence and Heterogeneity of Efflux Defects Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1139 - 1145. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sarov-Blat, R. S. Kiss, B. Haidar, N. Kavaslar, M. Jaye, M. Bertiaux, K. Steplewski, M. R. Hurle, D. Sprecher, R. McPherson, et al. Predominance of a Proinflammatory Phenotype in Monocyte-Derived Macrophages From Subjects With Low Plasma HDL-Cholesterol Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1115 - 1122. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Haidar, R. S. Kiss, L. Sarov-Blat, R. Brunet, C. Harder, R. McPherson, and Y. L. Marcel Cathepsin D, a Lysosomal Protease, Regulates ABCA1-mediated Lipid Efflux J. Biol. Chem., December 29, 2006; 281(52): 39971 - 39981. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |